STAT3 and hepatocellular carcinoma: Higher levels of p-STAT3 were also observed in the M2-CM + LPS group than in the M2-CM only group following the upregulation of TLR4 (Fig. 4b), and treatment with LPS alone did not obviously increase p-STAT3 levels in HCC cells (Fig. 4c).